CUDC-907, a dual inhibitor of PI3K and HDAC, can reduce MYCN levels in NB cells and increase H3K9Ac levels, promoting apoptosis (Chilamakuri and Agarwal, 2022). Here, MYCN is linked to neuroblastoma.